Introduction
Introduction

Ischaemic preconditioning (IP) is a powerful adaptive defence induced by mild ischaemia to increase resistance to future injurious ischaemia
. IP has aroused increasing attention in recent years because of its potential therapeutic significance [2] [3] [4] , yet it has not been employed clinically because of safety concerns [5] . It is therefore necessary to seek a safer preconditioning stimulus that is practical and effective, or a biological agent that is able to mimic preconditioning pharmacologically [4] [5] [6] . Recent studies have demonstrated that administration of halogenated anaesthetics and noble gas xenon can precondition the heart and the brain and attenuate damage to these organs [5] [6] [7] . [8, 9] . We chose GB in this study because it has been evidenced that GB is responsible for the neuroprotective role of ginkgolides [10] . Administration of GB improved stroke index scores and mitochondrial respiration following occlusion of the bilateral carotid arteries in gerbils [8] .
The aim of the present study was to see whether Ginkgolide B (GB) is capable of preconditioning as mild ischaemia to protect neurons against ischaemic injury, and to discuss possible mechanisms involved. GB is a main active monomer of ginkgolides, a unique group of diterpenes that are found naturally in the leaves of the Ginkgo biloba tree. Although ginkgolides are known to have neuroprotective properties, the actual mechanisms involved are not clear, for ginkgolides are a complex mixture containing ginkgolide A, B, C, J and various other constituents
Our recent studies [9, 11, 12] 
showed that ginkgolides had protective effects against hypoxic injury in PC12 cells or neurons and could mimic IP to protect C6 cells against ischaemic injury by up-regulation of hypoxia-inducible factor-1 alpha (HIF-1␣), a major regulator of oxygen homeostasis [13], as well as its target
Ginkgolide B preconditioning protects neurons against ischaemia-induced apoptosis
Neuronal culture
Cultures of pure cortical neurons were obtained from embryonic day 14 to 15 ICR mice as described previously [11] . 
Assessment of cell viability
Cell viability was assessed using a MTT assay or Lactate dehydrogenase (LDH) release as described previously [11] . In MTT assay, the yellow 3- 
Western blot analysis
Neurons were harvested in 150 l lysis buffer containing protease inhibitors [12] . 
Statistical analysis
Data were expressed as mean Ϯ S.D. The difference between means was determined by one-way anova followed by a Student-Newman-Keuls test for multiple comparisons. A probability value of P Ͻ 0.05 was taken to be statistically significant.
Results
Effects of ischaemia in different periods on cultured neurons
We first measured the viability of neurons in ischaemia for 0, 0. 
GB at 120 mol/l induced the highest increase in viabiliy of ischaemic neurons
We investigated the effects of different GB concentrations on viability of ischaemic neurons. The neurons were pre-incubated with 0, 60, 90, 120 and 150 mol/l of GB for 24 hrs before being treated with ischaemia for 5 hrs (severe ischaemia). It was found that neuronal viability increased progressively with the GB concentration increasing, reached the peak at 120 mol/l and then decreased at 150 mol/l (Fig. 2) . This dosage (120 mol/l) was therefore used in the following experiments.
Both GB and IP protected neurons against ischaemic injury
To find out whether there was any protective effect of IP against ischaemia, the neurons were pre-treated with ischaemia for 0.5 or 1 hr and then exposed to 21% O2 and complete DMEM for 24 hrs before being treated with ischaemia for 5 hrs. Meanwhile, sister neurons were pre-treated with GB for 24 hrs and then exposed to ischaemia for 5 hrs. It was found that cell viability in the ischaemic neurons pre-treated with GB or IP (0.5 or 1 hr) was significantly higher than that in the ischaemic neurons without pre-treatment (All P Ͻ 0.01 versus '0 hr ϩ 5 hrs', Fig. 3B ). These data were in agreement with the corresponding morphological changes (Fig. 3A) , demostrating that both GB and IP could significantly protect neurons against ischaemic injury. Interestingly, our results also showed that GB was able to raise viability of normal cultured neurons without ischaemic treatment (P Ͻ 0.05 versus 'control'), which was similar to our previous report for ginkgolides [17] . This suggested that GB might have a trophic action on neurons, which also implied the protective effect of GB against severe ischaemia. Fig. 4A and B) , whereas the neurons pretreated with GB or IP had relatively normal nuclei (Fig. 4D) .
Both GB and IP protected neurons against ischaemia-induced apoptosis
To (Fig.  4B-D) , implying that GB could prevent neurons from apoptosis either in ischaemia or in normal condition.
hr ϩ 5 hrs; c: IP 1 hr ϩ 5 hrs; d: GB ϩ 5 hrs, bar ϭ 1M). (B) Flow-cytometric histograms of PI-stained neurons (n ϭ 6). (C) A representative experiment of Western blot of cleaved caspase-3; (D) Quantification of expression of cleaved caspase-3 protein (n ϭ 3). *P Ͻ 0.05 versus control; **P Ͻ 0.01 versus control;
## P Ͻ 0.01 versus '0 hr ϩ 5 hrs'; P Ͼ 0.05 versus 'GB ϩ 5 hrs'. Fig. 5A and B [18, 19] (Fig. 6 ). This further indicated that GB or IP could exert neuroprotective effect through PI3K signalling pathway.
Fig. 4 Effects of Ginkgolide B or ischaemic preconditioning on ischaemiainduced neuronal apoptosis. Neurons were pre-treated with IP for 1 hr or GB for 24 hrs before exposure to ischaemia for 5 hrs and then stained by Hoechst 33342 or PI. The expression of cleaved caspase-3 was determined by Western blot. Control: neurons without treatment; GB: neurons treated only with GB for 24 hrs; 0 hr ϩ 5 hrs: neurons in ischaemia for 5 hrs without pre-treatment; IP ϩ 5 hrs: IP for 1 hr ϩ ischaemia for 5 hrs; GB ϩ 5 hrs: GB for 24 hrs ϩ ischaemia for 5 hrs. (A) Representative photographs of neuronal nucleus by Hoechst 33342 staining (a: control; b:
Fig. 5 Effects of Ginkgolide B or ischaemic preconditioning on expression of HIF-1␣, EPO, 136 p-Bad and p-GSK-3␤ in ischaemic neurons. Neurons were pre-treated with or without IP 1 hr or GB for 24 hrs before exposure to ischaemia for 5 hrs and expression of HIF-1␣, EPO, 136 p-Bad and p-GSK-3␤ was then determined by Western blot. (A, C, E and G) A representative experiment of Western blot of HIF-1␣, EPO 136 p-Bad and p-GSK-3␤; (B, D, F and H) Quantification of expression of HIF-1␣, EPO, 136 p-Bad and p-GSK-3␤ protein (n ϭ 3). *P Ͻ
Both GB and IP induced the expression of HIF-1␣, EPO, p-Bad and p-GSK-3␤ in ischaemic neurons
To understand potential mechanisms involved in GB or IP inhibited neuronal apoptosis induced by ischaemia, we investigated the effects of ischaemia in different periods on expression of HIF-1␣ in cultured neurons, and examined the effects of pretreatment with GB or IP on expression of HIF-1␣, EPO, 136 p-Bad and p-GSK-3␤ in severe ischaemic neurons by Western blot. It was found that the increase in level of HIF-1␣ protein began with ischaemia for 0.5 hr in cultured neurons, the level of HIF-1␣ protein induced by ischaemia for 1 hr was higher than that induced by ischaemia for 0.5 and 5 hrs (Fig. 5A and B). These results suggested that ischaemia for 1 hr could induce the highest expression of HIF-1␣ in cultured neurons. In addition, it was found that GB might raise the level of HIF-1␣ in normal cultured neurons without any other stimulus (
Meanwhile, it was also found that level of phosphorylation of GSK-3␤ that is an important kinase of PI3K pathway
LDH release was normalized by control as 100% (n ϭ 8). It is found that LDH release markedly increased after severe ischaemia, the pretreatment of GB or IP significantly decreased the LDH release in ischaemic neurons, which could be reversed by LY294002
Inhibition of phosphatidylinositol 3-kinase reduced expression of HIF-1␣, EPO and p-Bad induced by GB or IP in neurons
To further explore the mechanism of GB or IP in preventing neurons from ischaemia-induced apoptosis, the neurons were preincubated with or without 50 mol/l LY294002 for 1 hr before being treated with GB for 24 [21] . Hypoxia causes an increase in HIF-1␣ by preventing its degradation in response to low O2 tension, whereas the HIF-1␤ subunit is constitutively expressed [13, 21] . It is well known that HIF-1 and its target genes mediate critically hypoxia/ischaemia preconditioning in the brain [13, 20, 21] . Pre-treatment of neonatal rats with divalent cobalt chloride and iron chelating agent desferoxamine for 24 hrs before hypoxia/ischaemia afforded significant brain protection and increased HIF-1␣ content [13, 22] [27, 28] . Akt1 is one of these kinases that mediated the phosphorylation of Bad at Ser 136 [28] [29] [30] 
